10% one-year unsecured promissory note will convert at $1.60 per share
By Devika Patel
Knoxville, Tenn., April 6 – Biotricity Inc. raised $275,000 in an initial tranche of a $1 million private placement of 10% unsecured convertible promissory notes on March 31, according to an 8-K filed Wednesday with the Securities and Exchange Commission.
The notes mature in one year and are convertible into stock at $1.60 per share when the company conducts an equity financing of at least $3 million. The conversion price reflects a 41.95% discount to the April 5 closing share price of $2.28.
The investors will receive 100% warrant coverage when the company conducts an equity financing of at least $3 million.
Proceeds will be used for working capital and general corporate purposes.
The Toronto company designs biometric monitoring solutions for medical, health care and consumer use.
| Issuer: | Biotricity Inc.
|
| Issue: | Unsecured convertible promissory notes
|
| Amount: | $1 million
|
| Maturity: | One year
|
| Coupon: | 10%
|
| Conversion price: | $1.60
|
| Call: | Yes
|
| Warrants: | 100% coverage upon completion of a financing
|
| Settlement date: | March 31 (for $275,000)
|
| Stock symbol: | OTCBB: BTCY
|
| Stock price: | $2.28 at close April 5
|
| Market capitalization: | $57.75 million
|
|
|
|
|
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.
